www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

LL-37/CAP-18, Human, mAb 1-1C12

Catalogue number:
HM2071-100UG
Supplier:
Size:
100 µg _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£560.00 Shipping is calculated in checkout
Applications:

Immuno assays, Immuno fluorescence, Paraffin sections, Western blot

Immunogen:

mixture of synthetic native and glutaraldehyde cross-linked LL-37<sup>1sup>

Product Description:

The monoclonal antibody 1-1C12 recognizes free LL-37 as well as its precursor human CAP18 (hCAP18). hCAP18 is a cathelicidin protein of ~18 kDa. It belongs to the cathelicidin family of antimicrobial peptides that are characterised by a conserved N-terminal cathelin domain and a variable C-terminal antimicrobial domain. Cathelicidins are predominantly found in the peroxidase-negative granules of neutrophils. During bacterial infections, the life span of neutrophils is regulated by various pathogen- and host-derived substances. Within the neutrophils, the cathelicidins are synthesised as preproproteins. After removal of the signal peptide,they are stored in granules as inactive proforms. The C-terminal antimicrobial peptides are activated when cleaved from the proforms of the cathelicidins by serine proteases from azurophil granules.hCAP18 is a major protein in specific granules of neutrophils, but it is also present in subpopulations of lymphocytes and monocytes, in squamous epithelia (of the mouth, tongue, esophagus, cervix, and vagina), pulmonary epithelium, keratinocytes in inflammatory skin diseases and in the epididymus. The antibacterial C-terminus of hCAP18, LL-37 (37 amino acids), has been shown to exert broad antimicrobial activity towards gram-negative as well as gram-positive bacteria and to have synergistic antibacterial effects with the defensins. For instance deficiency in saliva, LL-37 accords with occurrence of periodontal disease in patients with morbus Kostmann. LL-37 does not only kill bacteria, but can also modulate (suppress) neutrophil apoptosis via the activation of FPRL1 and P2X7 in bacterial infections. Suppression of neutrophil apoptosis results in the prolongation of their life span, and may be advantageous for host defense against bacterial invasion. Moreover it functions as a chemotactic agent for neutrophils, monocytes and T cells. LL-37 is markedly resistant to proteolytic degradation and to a limited extent also cytotoxic towards mammalian cells.

HM2071-100UG LL-37/CAP-18, Human, mAb 1-
HM2071-100UG LL-37/CAP-18, Human, mAb 1-1C12
Details Cat number & supplier Size Price
Ficolin-3, Human, mAb 4H5 HM2089-100UG · Hycult Biotech
HM2089-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
LL-37/CAP-18, Human, mAb 3D11 HM2070-100UG · Hycult Biotech
HM2070-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
Ficolin-2, Human, mAb GN4 HM2090-100UG · Hycult Biotech
HM2090-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
Elafin, Human, mAb TRAB2F HM2063-100UG · Hycult Biotech
HM2063-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
Ficolin-2, Human, mAb GN5 HM2091-100UG · Hycult Biotech
HM2091-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
Elafin, Human, mAb TRAB2O HM2062-100UG · Hycult Biotech
HM2062-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
MASP-1/3, Human, mAb 1E2 HM2092-100UG · Hycult Biotech
HM2092-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
MBL, Human, mAb 3E7 HM2061-100UG · Hycult Biotech
HM2061-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
MASP-1/3, Human, mAb 2B11 HM2093-100UG · Hycult Biotech
HM2093-100UG
Hycult Biotech
100 µg £560.00
100 µg
view
Mannose receptor, Human, mAb 15-2 HM2056-100UG · Hycult Biotech
HM2056-100UG
Hycult Biotech
100 µg £560.00
100 µg
view